A. König

Improving ICD-based semantic similarity by accounting for varying degrees of comorbidity

U. Sax, Jonas Hügel, Jan Janosch Schneider, 2023, ArXiv.

Time to Deliver on Promises: The Role of ERBB2 Alterations as Treatment Options for Colorectal Cancer Patients in the Era of Precision Oncology

H. Bohnenberger, K. Reuter-Jessen, P. Ströbel, 2023, Journal of personalized medicine.

Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer—Results of the prospective multicenter PERMAD trial

Angelika M. R. Kestler, Silke D. Werle, L. Lausser, 2024, PloS one.